Kendra Harris, MDc, PhDc

MD/PhD Student, Weill Cornell Medical College Tri-Institutional Program/Rockefeller/Sloan-Kettering

Fellowship Site: GHESKIO, Haiti

Research Interests: Activity of a novel antimycobacterial against multidrug-resistant and non-replicating clinical isolates of Mycobacterium tuberculosis from Haiti

Ms. Harris will spend her fellowship year at Le Groupe Hatien d’Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) in Port-au-Prince, under the mentorship of Michael Glickman, MD. Her research will focus on determining the antimycobacterial activity of a novel small molecule compound against multidrug-resistant and nonreplicating Mycobacterium tuberculosis clinical isolates in order to assess the potential efficacy of this compound as a novel drug for the treatment of M. tuberculosis infection.

Ms. Harris received her bachelor’s degree in molecular biology from Princeton University. She subsequently joined the Aeras Global Tuberculosis Vaccine Foundation as a Public Health Fellow. Ms. Harris is now an MD-PhD student in the Weill Cornell Medical College Tri-Institutional MD-PhD Program, where her graduate research investigates a novel antimycobacterial compound to determine its potential utility in the treatment of tuberculosis. Ms. Harris has volunteered with humanitarian organizations in Rwanda, Africa and is interested in global health. She plans to pursue a clinical residency in internal medicine with the goal of conducting translational research focused on infectious diseases prevalent in resource-limited areas globally.

View all publications by Kendra Harris